Steven P Lehrer (S Lehrer, Steven Lehrer)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 16

Top Topics

Radical Prostatectomy

Prostate Cancer

Chronic Obstructive Pulmonary Disease

Top Venues

Chronic diseases and translational medicine

Journal of the National Cancer Institute

Journal of the European Academy of Dermatology and Venereology : JEADV

This page only lists publications with an associated author ORCID identifier.

Publications

Steven P Lehrer, Peter H Rheinstein
Alignment of human aquaporin 4 and ß-amyloid proteins may indicate involvement of ß-amyloid in brain water homeostasis and prevention of brain edema. Chronic diseases and translational medicine 9 (2) (2023)
Steven P Lehrer, Peter H Rheinstein
Increased survival of women with luminal breast cancer and progesterone receptor immunohistochemical expression of greater than 10. Cancer (2023)
Steven P Lehrer, P H Rheinstein
Genome-wide association study of dermatophytosis in the UK Biobank cohort. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (12) (2022)
Steven P Lehrer, Peter H Rheinstein
Neither tamoxifen nor aromatase inhibitors increase the risk of Parkinson disease in the UK Biobank cohort. Cancer 128 (15) (2022)
Steven P Lehrer, Peter H Rheinstein
RE: Nitrogen-Based Bisphosphonate Use and Ovarian Cancer Risk in Women Aged 50 Years and Older. Journal of the National Cancer Institute 114 (10) (2022)
Steven P Lehrer, Peter H Rheinstein
Breast cancer and body weight changes of young women in the UK Biobank cohort. Cancer 128 (19) (2022)
Steven P Lehrer, Peter H Rheinstein
Shingles vaccination reduces the risk of Parkinson's disease. Chronic diseases and translational medicine 9 (1) (2022)
Steven P Lehrer, Peter H Rheinstein
Alignment of human KAT2A (GCN5) histone acetyltransferase and SARS-CoV-2 Orf8 viral proteins. Chronic diseases and translational medicine (2022)
Steven P Lehrer, Peter H Rheinstein
Alignment of human KAT2A (GCN5) histone acetyltransferase and SARS-CoV-2 Orf8 viral proteins. Chronic diseases and translational medicine (2022)
Steven P Lehrer, Peter H Rheinstein
Association of cannabis with chronic obstructive pulmonary disease and COVID-19 infection. Chronic diseases and translational medicine 8 (3) (2022)
Steven P Lehrer, Peter H Rheinstein
Shingles vaccination reduces the risk of Parkinson's disease. Chronic diseases and translational medicine 9 (1) (2022)
Steven P Lehrer, Peter H Rheinstein
α-synuclein enfolds tyrosine hydroxylase and dopamine ß-hydroxylase, potentially reducing dopamine and norepinephrine synthesis. Journal of proteins and proteomics 13 (2) (2022)
Steven P Lehrer, Peter H Rheinstein
FBXW7, L1CAM, and TGM2 in endometrial cancer. Cancer 127 (21) (2021)
Steven P Lehrer, Peter H Rheinstein
The 5-year relative survival of older patients with prostate cancer is insignificantly different from the 5-year survival of all men of a similar age. Cancer 126 (11) (2020)
Steven P Lehrer
Obesity and aggressive prostate cancer. Cancer 126 (10) (2020)
Steven P Lehrer, Peter H Rheinstein, Kenneth E Rosenzweig
Improving the survival of patients with American Joint Committee on Cancer stage III and IV melanoma. Cancer 124 (10) (2018)